{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T21:14:18Z","timestamp":1793826858631,"version":"4.6.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003359","name":"Generalitat Valenciana","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003359","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Urologic Oncology: Seminars and Original Investigations"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.urolonc.2019.08.005","type":"journal-article","created":{"date-parts":[[2019,9,12]],"date-time":"2019-09-12T00:15:27Z","timestamp":1568247327000},"page":"976-987","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Frailty syndrome is associated with changes in peripheral inflammatory markers in prostate cancer patients undergoing androgen deprivation therapy"],"prefix":"10.1016","volume":"37","author":[{"given":"Rut","family":"Navarro-Mart\u00ednez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Serrano-Carrascosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Buigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Fern\u00e1ndez-Garrido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"S\u00e1nchez-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana B.","family":"Castell\u00f3-Domenech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Garc\u00eda-Villodre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augusto","family":"Wong-Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Rubio-Briones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Cauli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.urolonc.2019.08.005_bib0001","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/aja.2011.103","article-title":"Use of androgen deprivation therapy in prostate cancer: indications and prevalence","volume":"14","author":"Connolly","year":"2012","journal-title":"Asian J Androl"},{"issue":"9660","key":"10.1016\/j.urolonc.2019.08.005_bib0002","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0140-6736(08)61815-2","article-title":"Endocrine treatment, with or without radiotherapy, in locally advanced prostate cancer (SPCG-7\/SFUO-3): an open randomised phase III trial","volume":"373","author":"Widmark","year":"2009","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.urolonc.2019.08.005_bib0003","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1464-410X.2008.07539.x","article-title":"Changes in muscle, fat and bone mass after 36 weeks of maximal androgen blockade for prostate cancer","volume":"102","author":"Galv\u00e3o","year":"2008","journal-title":"BJU Int"},{"issue":"2","key":"10.1016\/j.urolonc.2019.08.005_bib0004","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1210\/jcem.87.2.8299","article-title":"Changes in body composition during androgen deprivation therapy for prostate cancer","volume":"87","author":"Smith","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"10.1016\/j.urolonc.2019.08.005_bib0005","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/pcan.2008.51","article-title":"Reduced muscle strength and functional performance in men with prostate cancer undergoing androgen suppression: a comprehensive cross-sectional investigation","volume":"12","author":"Galv\u00e3o","year":"2009","journal-title":"Prostate Cancer Prostatic Dis"},{"issue":"4","key":"10.1016\/j.urolonc.2019.08.005_bib0006","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.urology.2010.11.024","article-title":"Obese frailty, physical performance deficits, and falls in older men with biochemical recurrence of prostate cancer on androgen deprivation therapy: a case-control study","volume":"77","author":"Bylow","year":"2011","journal-title":"Urology"},{"issue":"3","key":"10.1016\/j.urolonc.2019.08.005_bib0007","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1111\/j.1532-5415.2009.02137.x","article-title":"A comparison of frailty indexes for the prediction of falls, disability, fractures, and mortality in older men","volume":"57","author":"Ensrud","year":"2009","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.urolonc.2019.08.005_bib0008","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.exger.2018.01.007","article-title":"Frailty and leucocyte count are predictors of all-cause mortality and hospitalization length in non-demented institutionalized older women","volume":"103","author":"Fern\u00e1ndez-Garrido","year":"2018","journal-title":"Exp Gerontol"},{"issue":"3","key":"10.1016\/j.urolonc.2019.08.005_bib0009","doi-asserted-by":"crossref","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","article-title":"Cardiovascular Health Study Collaborative Research Group. Frailty in older adults: evidence for a phenotype","volume":"56","author":"Fried","year":"2001","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.urolonc.2019.08.005_bib0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0047-6374(00)00094-4","article-title":"Distinct categories of immunologic changes in frail elderly","volume":"15","author":"Fahey","year":"2000","journal-title":"Mech Ageing Dev"},{"key":"10.1016\/j.urolonc.2019.08.005_bib0011","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/j.1749-6632.2000.tb06651.x","article-title":"Inflamm-aging. An evolutionary perspective on immunosenescence","volume":"908","author":"Franceschi","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.urolonc.2019.08.005_bib0012","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.mad.2016.12.008","article-title":"Inflammaging and human longevity in the omics era","volume":"165","author":"Monti","year":"2017","journal-title":"Mech Ageing Dev"},{"issue":"1","key":"10.1016\/j.urolonc.2019.08.005_bib0013","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.cger.2010.08.002","article-title":"Inflammation and immune system alterations in frailty","volume":"27","author":"Yao","year":"2011","journal-title":"Clin Geriatr Med"},{"key":"10.1016\/j.urolonc.2019.08.005_bib0014","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.arr.2018.07.004","article-title":"Towards frailty biomarkers: candidates from genes and pathways regulated in aging andage-related diseases","volume":"47","author":"Cardoso","year":"2018","journal-title":"Ageing Res Rev"},{"issue":"1","key":"10.1016\/j.urolonc.2019.08.005_bib0015","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.archger.2014.02.008","article-title":"Clinical features of prefrail older individuals and emerging peripheralbiomarkers: a systematic review","volume":"59","author":"Fern\u00e1ndez-Garrido","year":"2014","journal-title":"Arch Gerontol Geriatr"},{"key":"10.1016\/j.urolonc.2019.08.005_bib0016","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.mad.2019.03.007","article-title":"Frailty biomarkers in humans and rodents: current approaches and future advances","volume":"180","author":"Kane","year":"2019","journal-title":"Mech Ageing Dev"},{"issue":"6","key":"10.1016\/j.urolonc.2019.08.005_bib0017","doi-asserted-by":"crossref","first-page":"461","DOI":"10.14740\/jocmr2959w","article-title":"C-reactive protein and frailty in the elderly: a literature review","volume":"9","author":"Velissaris","year":"2017","journal-title":"J Clin Med Res"},{"issue":"1","key":"10.1016\/j.urolonc.2019.08.005_bib0018","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1177\/1099800418798047","article-title":"Biological processes and biomarkers related to frailty in older adults: a state-of-the-science literature review","volume":"21","author":"Wang","year":"2019","journal-title":"Biol Res Nurs"},{"issue":"6","key":"10.1016\/j.urolonc.2019.08.005_bib0019","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.mad.2012.05.005","article-title":"Frailty and the role of inflammation, immunosenescence and cellular ageing in the very old: cross-sectional findings from the Newcastle 85+ Study","volume":"133","author":"Collerton","year":"2012","journal-title":"Mech Ageing Dev"},{"key":"10.1016\/j.urolonc.2019.08.005_bib0020","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.exger.2013.11.019","article-title":"The value of neutrophil and lymphocyte count in frail older women","volume":"54","author":"Fern\u00e1ndez-Garrido","year":"2014","journal-title":"Exp Gerontol"},{"issue":"6","key":"10.1016\/j.urolonc.2019.08.005_bib0021","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/annonc\/mdu540","article-title":"The prevalence and outcomes of frailty in older cancer patients: a systematic review","volume":"26","author":"Handforth","year":"2015","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.urolonc.2019.08.005_bib0022","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s10549-017-4222-8","article-title":"Frailty and long-term mortality of older breast cancer patients: CALGB 369901 (Alliance)","volume":"164","author":"Mandelblatt","year":"2017","journal-title":"Breast Cancer Res Treat"},{"issue":"1","key":"10.1016\/j.urolonc.2019.08.005_bib0023","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s11060-017-2644-0","article-title":"The modified frailty index and 30-day adverse events in oncologic neurosurgery","volume":"136","author":"Youngerman","year":"2018","journal-title":"J Neurooncol"},{"key":"10.1016\/j.urolonc.2019.08.005_bib0024","doi-asserted-by":"crossref","first-page":"M85","DOI":"10.1093\/geronj\/49.2.M85","article-title":"A short physical performance battery assessing lower extremity function: association with self-reported disability and prediction of mortality and nursing home admission","volume":"49","author":"Guralnik","year":"1994","journal-title":"J Gerontol"},{"key":"10.1016\/j.urolonc.2019.08.005_bib0025","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1053\/apmr.2002.34619","article-title":"The reliability of upper- and lower-extremity strength testing in a community survey of older adults","volume":"83","author":"Ottenbacher","year":"2002","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.urolonc.2019.08.005_bib0026","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1146\/annurev.med.51.1.245","article-title":"Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty","volume":"51","author":"Ershler","year":"2000","journal-title":"Annu Rev Med"},{"issue":"12","key":"10.1016\/j.urolonc.2019.08.005_bib0027","doi-asserted-by":"crossref","DOI":"10.3390\/jcm7120549","article-title":"Do androgens modulate the pathophysiological pathways of inflammation? Appraising the contemporary evidence","volume":"7","author":"Traish","year":"2018","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.urolonc.2019.08.005_bib0028","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0090-4295(98)00455-5","article-title":"Interleukin-8 serum levels in patients with benign prostatic hyperplasia and prostate cancer","volume":"53","author":"Veltri","year":"1999","journal-title":"Urology"},{"issue":"5","key":"10.1016\/j.urolonc.2019.08.005_bib0029","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1177\/153303460400300501","article-title":"Serum interleukin-8 is elevated in men with prostate cancer and bone metastases","volume":"3","author":"Lehrer","year":"2004","journal-title":"Technol Cancer ResTreat"},{"issue":"2","key":"10.1016\/j.urolonc.2019.08.005_bib0030","doi-asserted-by":"crossref","first-page":"FSO266","DOI":"10.4155\/fsoa-2017-0084","article-title":"A prospective clinical study of the implications of IL-8 in the diagnosis, aggressiveness and prognosis of prostate cancer","volume":"4","author":"Roumegu\u00e8re","year":"2017","journal-title":"Future Sci OA"},{"key":"10.1016\/j.urolonc.2019.08.005_bib0031","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.exger.2016.01.008","article-title":"Muscle function and fat content in relation to sarcopenia, obesity and frailty of old age\u2013an overview","volume":"76","author":"Buch","year":"2016","journal-title":"Exp Gerontol"},{"key":"10.1016\/j.urolonc.2019.08.005_bib0032","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1111\/j.1532-5415.2005.53300.x","article-title":"The association between obesity and the frailty syndrome in older women: the women's health and aging studies","volume":"53","author":"Blaum","year":"2005","journal-title":"J Am Geriatr Soc"},{"issue":"9B","key":"10.1016\/j.urolonc.2019.08.005_bib0033","doi-asserted-by":"crossref","first-page":"3103","DOI":"10.1111\/j.1582-4934.2009.00733.x","article-title":"Inflammation and frailty measures in older people","volume":"13","author":"Hubbard","year":"2009","journal-title":"J Cell Mol Med"},{"issue":"5","key":"10.1016\/j.urolonc.2019.08.005_bib0034","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1093\/ageing\/afx023","article-title":"Metabolic syndrome and insulin resistance are associated with frailty in older adults: a prospective cohort study","volume":"46","author":"P\u00e9rez-Tasigchana","year":"2017","journal-title":"Age Ageing"},{"issue":"9","key":"10.1016\/j.urolonc.2019.08.005_bib0035","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1111\/j.1532-5415.2009.02392.x","article-title":"High oxidative stress is correlated with frailty in elderly Chinese","volume":"57","author":"Wu","year":"2009","journal-title":"J Am Geriatr Soc"},{"issue":"12","key":"10.1016\/j.urolonc.2019.08.005_bib0036","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1111\/ggi.13099","article-title":"Association between frailty and carotid intima media thickness and inflammatory marker in an elderly population","volume":"17","author":"Chang","year":"2017","journal-title":"Geriatr Gerontol Int"},{"issue":"8","key":"10.1016\/j.urolonc.2019.08.005_bib0037","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1038\/bjc.2017.280","article-title":"Cardiovascular disease risk and androgen deprivation therapy in patients with localized prostate cancer: a prospective cohort study","volume":"117","author":"Haque","year":"2017","journal-title":"Br J Cancer"},{"issue":"2\u20133","key":"10.1016\/j.urolonc.2019.08.005_bib0038","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1385\/IR:23:2-3:281","article-title":"Effects of androgens on T and B lymphocyte development","volume":"23","author":"Olsen","year":"2001","journal-title":"Immunol Res"},{"issue":"5","key":"10.1016\/j.urolonc.2019.08.005_bib0039","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1111\/j.1532-5415.2008.01673.x","article-title":"T-lymphocytes expressing CC chemokine receptor-5 are increased in frail older adults","volume":"56","author":"De Fanis","year":"2008","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.urolonc.2019.08.005_bib0040","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.3389\/fimmu.2018.01056","article-title":"Frailty in older adults is associated with plasma concentrations of inflammatory mediators but not with lymphocyte subpopulations","volume":"9","author":"Marcos-P\u00e9rez","year":"2018","journal-title":"Front Immunol"},{"issue":"10","key":"10.1016\/j.urolonc.2019.08.005_bib0041","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1046\/j.1532-5415.2003.51467.x","article-title":"Lymphocyte count and mortality risk in older persons. The Leiden 85-Plus Study","volume":"51","author":"Izaks","year":"2003","journal-title":"J Am Geriatr Soc"},{"issue":"1\u20132","key":"10.1016\/j.urolonc.2019.08.005_bib0042","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.exger.2004.09.006","article-title":"T cell subsets and mortality in older community-dwelling women","volume":"40","author":"Semba","year":"2005","journal-title":"Exp Gerontol"},{"issue":"1","key":"10.1016\/j.urolonc.2019.08.005_bib0043","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1186\/s12885-017-3498-8","article-title":"Lymphocyte count or percentage: which can better predict the prognosis of advanced cancer patients following palliative care?","volume":"17","author":"Zhao","year":"2017","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.urolonc.2019.08.005_bib0044","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/aja.2011.103","article-title":"Use of androgen deprivation therapy in prostate cancer: indications and prevalence","volume":"14","author":"Connolly","year":"2012","journal-title":"Asian J Androl"},{"issue":"1","key":"10.1016\/j.urolonc.2019.08.005_bib0045","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.jcjd.2015.09.004","article-title":"Diabetes and frailty: two converging conditions?","volume":"40","author":"Sinclair","year":"2016","journal-title":"Can J Diabetes"},{"issue":"6","key":"10.1016\/j.urolonc.2019.08.005_bib0046","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.jamda.2013.03.022","article-title":"Frailty consensus: a call to action","volume":"14","author":"Morley","year":"2013","journal-title":"J Am Med Dir Assoc"},{"issue":"7","key":"10.1016\/j.urolonc.2019.08.005_bib0047","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1111\/jgs.14795","article-title":"Falls and frailty in prostate cancer survivors: current, past, and never users of androgen deprivation therapy","volume":"65","author":"Winters-Stone","year":"2017","journal-title":"J Am Geriatr Soc"},{"issue":"2","key":"10.1016\/j.urolonc.2019.08.005_bib0048","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1080\/13685538.2016.1277516","article-title":"Use of geriatric assessment and screening tools of frailty in elderly patients with prostate cancer","volume":"20","author":"Molina-Garrido","year":"2017","journal-title":"Rev Aging Male"},{"issue":"4","key":"10.1016\/j.urolonc.2019.08.005_bib0049","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.eururo.2016.12.025","article-title":"Management of prostate cancer in elderly patients: recommendations of a task force of the international society of geriatric oncology","volume":"72","author":"Droz","year":"2017","journal-title":"Eur Urol"}],"container-title":["Urologic Oncology: Seminars and Original Investigations"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143919303230?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078143919303230?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T10:16:30Z","timestamp":1761041790000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078143919303230"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":49,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S1078143919303230"],"URL":"https:\/\/doi.org\/10.1016\/j.urolonc.2019.08.005","relation":{},"ISSN":["1078-1439"],"issn-type":[{"value":"1078-1439","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Frailty syndrome is associated with changes in peripheral inflammatory markers in prostate cancer patients undergoing androgen deprivation therapy","name":"articletitle","label":"Article Title"},{"value":"Urologic Oncology: Seminars and Original Investigations","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.urolonc.2019.08.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}